Affilogic
Mathieu Cinier is a seasoned professional in the field of biochemistry and organic chemistry, currently serving as the Scientific Director and R&D Project Manager at Affilogic since November 2011. Prior to this role, Mathieu Cinier gained valuable experience as a Postdoctoral Fellow at Dr. Guo's lab at the University of Cincinnati from December 2009 to July 2011. Mathieu's academic background includes a PhD in Biochemistry and Organic Chemistry from Nantes Université, completed between 2006 and 2009, following studies at the University of Nantes starting in October 2006.
This person is not in any teams
Affilogic
Affilogic is a private biotech company specialised in discovering and developing Nanofitins® through early-stage collaborations with worldwide industry leaders in the pharmaceutical sector. These affinity proteins are potent antibody-mimetics, exhibiting a high affinity and specificity for capture, targeting and interacting with biomolecules. Each Nanofitin® is 20 times smaller than an antibody (7 kDa) and demonstrates hyper stability. Nanofitins are easily combined with each other, antibodies and other biomolecules by simple, rapid and proven methods to design an ideal targeted molecule. Affilogic has designed Nanofitins® against 60+ targets to date, including a wide range of circulating antigens (peptides, proteins), membrane receptors for inhibition / modulation (GPCR, ion channels) and complex entities (virus-like particles, bacteria, whole cells).